{
    "xml": "<topic id=\"PHP96843\" outputclass=\"clinicalMedicinalProductInformation\" type=\"clinicalMedicinalProductInformation\" namespace=\"/clinical-medicinal-product-information/migraleve\" basename=\"migraleve\" title=\"Migraleve\">\n<title>Migraleve<tm tmtype=\"reg\"/>\n</title>\n<topic id=\"PHP96863\" outputclass=\"indicationsAndDose\" rev=\"1.27\" parent=\"/clinical-medicinal-product-information/migraleve\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Acute migraine</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 15&#8211;17 years</p>\n<p>Initially 2&#8239;tablets, (pink tablets) to be taken at onset of attack, followed by 2&#8239;tablets every 4&#8239;hours if required, (yellow tablets) to be taken following initial dose; maximum 2 pink and 6 yellow tablets in 24 hours.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 2&#8239;tablets, (pink tablets) to be taken at onset of attack, followed by 2&#8239;tablets every 4&#8239;hours if required, (yellow tablets) to be taken following initial dose; maximum 2 pink and 6 yellow tablets in 24 hours.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Acute migraine</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 12&#8211;14 years</p>\n<p>Initially 1&#8239;tablet, (pink tablet) to be taken at onset of attack, or if it is imminent, followed by 1&#8239;tablet every 4&#8239;hours if required, (yellow tablet) to be taken following initial dose; maximum 1 pink and 3 yellow tablets in 24 hours.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP96952\" outputclass=\"lessSuitableForPrescribing\" rev=\"1.8\" parent=\"/clinical-medicinal-product-information/migraleve\">\n<title>Less suitable for prescribing</title>\n<body>\n<section>\n<sectiondiv>\n<p>\n<i>Migraleve</i>\n<tm tmtype=\"reg\"/> is less suitable for prescribing.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"clinicalMedicinalProductInformation\" href=\"#clinicalMedicinalProductInformation\" title=\"Clinical medicinal product information\" namespace=\"/clinical-medicinal-product-information\">Clinical medicinal product information</xref>\n</parents>\n<backlinks/>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"#clinicalMedicinalProductInformation\" href=\"#clinicalMedicinalProductInformation\" namespace=\"/clinical-medicinal-product-information\" title=\"Clinical medicinal product information\" count=\"1\" rel=\"link\">Clinical medicinal product information</xref>\n</links>\n</topic>",
    "id": "PHP96843",
    "outputclass": "clinicalMedicinalProductInformation",
    "type": "clinicalMedicinalProductInformation",
    "namespace": "/clinical-medicinal-product-information/migraleve",
    "basename": "migraleve",
    "title": "Migraleve",
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Acute migraine",
                        "html": "Acute migraine"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "child": [
                    {
                        "textContent": "Initially 2 tablets, (pink tablets) to be taken at onset of attack, followed by 2 tablets every 4 hours if required, (yellow tablets) to be taken following initial dose; maximum 2 pink and 6 yellow tablets in 24 hours.",
                        "html": "<p>Initially 2&#8239;tablets, (pink tablets) to be taken at onset of attack, followed by 2&#8239;tablets every 4&#8239;hours if required, (yellow tablets) to be taken following initial dose; maximum 2 pink and 6 yellow tablets in 24 hours.</p>",
                        "ageGroup": "15&#8211;17 years"
                    }
                ],
                "adult": [
                    {
                        "textContent": "Initially 2 tablets, (pink tablets) to be taken at onset of attack, followed by 2 tablets every 4 hours if required, (yellow tablets) to be taken following initial dose; maximum 2 pink and 6 yellow tablets in 24 hours.",
                        "html": "<p>Initially 2&#8239;tablets, (pink tablets) to be taken at onset of attack, followed by 2&#8239;tablets every 4&#8239;hours if required, (yellow tablets) to be taken following initial dose; maximum 2 pink and 6 yellow tablets in 24 hours.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Acute migraine",
                        "html": "Acute migraine"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "child": [
                    {
                        "textContent": "Initially 1 tablet, (pink tablet) to be taken at onset of attack, or if it is imminent, followed by 1 tablet every 4 hours if required, (yellow tablet) to be taken following initial dose; maximum 1 pink and 3 yellow tablets in 24 hours.",
                        "html": "<p>Initially 1&#8239;tablet, (pink tablet) to be taken at onset of attack, or if it is imminent, followed by 1&#8239;tablet every 4&#8239;hours if required, (yellow tablet) to be taken following initial dose; maximum 1 pink and 3 yellow tablets in 24 hours.</p>",
                        "ageGroup": "12&#8211;14 years"
                    }
                ]
            }
        ]
    },
    "lessSuitableForPrescribing": {
        "lessSuitableForPrescribing": [
            {
                "type": "lessSuitableForPrescribing",
                "textContent": "Migraleve is less suitable for prescribing.",
                "html": "<p>\n<i>Migraleve</i>\n<tm tmtype=\"reg\"/> is less suitable for prescribing.</p>"
            }
        ]
    },
    "backlinks": {},
    "links": {
        "#clinicalMedicinalProductInformation": [
            {
                "id": "clinicalMedicinalProductInformation",
                "label": "Clinical medicinal product information",
                "type": "#clinicalMedicinalProductInformation"
            }
        ]
    }
}